SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial
SPIOMET4HEALTH——生活方式干预联合螺内酯、吡格列酮和二甲双胍固定剂量复方制剂（SPIOMET）治疗多囊卵巢综合征青少年女性和年轻女性的疗效、耐受性和安全性：一项多中心、随机、双盲、安慰剂对照、四臂、平行组、II期临床试验的研究方案
期刊:Trials
影响因子:2
doi:10.1186/s13063-023-07593-6
Garcia-Beltran, Cristina; Malpique, Rita; Andersen, Marianne S; Bas, Firdevs; Bassols, Judit; Darendeliler, Feyza; Díaz, Marta; Dieris, Barbara; Fanelli, Flaminia; Fröhlich-Reiterer, Elke; Gambineri, Alessandra; Glintborg, Dorte; López-Bermejo, Abel; Mann, Christopher; Marin, Silvia; Obermayer-Pietsch, Barbara; Ødegård, Rønnaug; Ravn, Pernille; Reinehr, Thomas; Renzulli, Matteo; Salvador, Cristina; Singer, Viola; Vanky, Eszter; Torres, Juan Vicente; Yildiz, Melek; de Zegher, Francis; Ibáñez, Lourdes
